Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up taking into account A1C and the main cardiovascular risk factors. RESEARCH DESIGN AND METHODS: Consecutive type 2 diabetic patients (n = 505) followed up at our diabetes clinic were evaluated at baseline (1995) for the main cardiovascular risk factors and for five glycemic control parameters (fasting blood glucose, blood glucose 2 h after breakfast, blood glucose 2 h after lunch, blood glucose before dinner, and A1C); all-cause mortality and the first cardiovascular events occurring during the 14-year follow-up were measured. RESULTS: We observed 172 cardiovascular events (34.1% of the population) and 147 deaths (29.1% of the population). Using the Cox analysis with the backward method, we categorized the variables according to the therapeutic targets of the American Diabetes Association. Our observations were as follows. When the five glycemic control parameters were considered together, the predictors were 1) for cardiovascular events, blood glucose 2 h after lunch (hazard ratio 1.507, P = 0.010) and A1C (1.792, P = 0.002); and 2) for mortality, blood glucose 2 h after lunch (1.885, P < 0.0001) and A1C (1.907, P = 0.002). When blood glucose 2 h after lunch and A1C were considered together with the main cardiovascular risk factors, the following glycemic control parameters were predictors: 1) for cardiovascular events, blood glucose 2 h after lunch (1.452, P = 0.021) and A1C (1.732, P = 0.004); and 2) for mortality, blood glucose 2 h after lunch (1.846, P = 0.001) and A1C (1.896, P = 0.004). CONCLUSIONS: In type 2 diabetes, both postprandial blood glucose and A1C predict cardiovascular events and all-cause mortality in a long-term follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, elevated 2 h postprandial glucose levels have been associated with a 50% greater risk of cardiovascular events and an 89% increase in all‐cause mortality (Cavalot et al., 2011).”
From Acute systemic and energy metabolism responses to velocity-based resistance training following an oral glucose load in individuals with excess body weight (2026) · cites this paper as Cavalot et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 1×
“The specific contribution of FBG and postprandial blood glucose to A1C was considered in detail elsewhere (22,23); in our study, the correlation of these two variables with A1C is similar.”
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · cited 1×
“It has been shown that reduction of hyperglycemia prevents diabetes macrovascular disease; in particular, a metaanalysis of randomized controlled trials evaluating the effects on cardiovascular outcomes and mortality of intensive blood glucose control policies targeting A1C showed a beneficial effect on coronary event…”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874 · cited 3×
“Note also that all patients considered in that study were on hypoglycemic treatment (24): either combination oral regimen with a sulphonylurea plus metformin or insulin, with or without concomitant oral agents; thus, they were at hypoglycemic risk.”
InfluentialHanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873 · cited 13×
“Our study, therefore, confirms that which has been observed in the 11-year follow-up of the DIS concerning FBG (9).”
BackgroundResultInfluentialLevitan, E. B., Song, Y., Ford, E. S., & Liu, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2147 · Cited by 668 · cited 1×
“Furthermore, a meta-analysis of 38 prospective studies carried out in nondiabetic subjects confirmed a strong association between 2-h postchallenge blood glucose with fatal and nonfatal cardiovascular events (3), and a linear relationship between this parameter and the risk of cardiovascular death has been observed (4…”
BackgroundHanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641 · cited 1×
“The following evidence is available: 1) a meta-analysis of seven randomized controlled trials in type 2 diabetes indicates that acarbose, a drug that corrects postprandial hyperglycemia by impairing carbohydrate absorption, reduces the occurrence of cardiovascular events; this effect has also been described in patient…”
BackgroundCavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569 · cited 8×
“This kind of categorization was the same as that used in the 5-year follow-up (10).”
BackgroundMethodResultInfluentialSelf-citationFasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
“…of TIIDM (American Diabetes Association., 2015a), cardiovascular disease (Gallwitz, 2009), and liver cirrhosis (Nishida et al., 2006) and is associated with obesity (Blaak et al., 2012), and enhanced all-cause mortality in both TIIDM (Cavalot et al., 2011) and cancer (Lamkin et al., 2009).”
Background(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Augustin, L. S. A., Kendall, C. W. C., Jenkins, D. J. A., Willett, W. C., Astrup, A., Barclay, A. W., Björck, I., Brand-Miller, J. C., Brighenti, F., Buyken, A. E., et al. (2015) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.005 · Cited by 707
Loh, R., Stamatakis, E., Folkerts, D., Allgrove, J. E., & Moir, H. J. (2020) · Sports Medicine · doi:10.1007/s40279-019-01183-w · Cited by 326
“Hyperglycaemic spikes are more strongly associated with, and might be more predictive of cardiovascular complications, risk and all-cause mortality than fasting plasma glucose or HbA1c levels [102] and should be targeted [103] since HbA1c is an integrative measure of blood glucose and post-prandial hyperglycaemia occu…”
BackgroundBread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses
Korem, T., Zeevi, D., Zmora, N., Weissbrod, O., Bar, N., Lotan-Pompan, M., Avnit-Sagi, T., Kosower, N., Malka, G., Rein, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.002 · Cited by 318
A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2014) · Diabetes Care · doi:10.2337/dc14-0845 · Cited by 260
“PPG excursions represent a component of GV that has shown to be an independent CVD risk factor (38).”
Cassidy, S., Thoma, C., Houghton, D., & Trenell, M. I. (2017) · Diabetologia · doi:10.1007/s00125-016-4106-1 · Cited by 239
“Since postprandial glucose excursions are strong predictors of cardiovascular disease [27], which may be due to possible inductions of oxidative stress and micro/macrovascular damage [28], the above findings are of clinical relevance.”
BackgroundThe Task Force on diabetes, P.-D. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 236
Silva, F. M., Kramer, C. K., de Almeida, J. C., Steemburgo, T., Gross, J. L., & Azevedo, M. J. (2013) · Nutrition Reviews · doi:10.1111/nure.12076 · Cited by 226
Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 195
“In the San Luigi Gonzaga Diabetes Study, a 14-year follow-up of 505 patients with T2DM, HbA1c and 2 h postprandial blood glucose level after lunch were significantly associated with CVD events and mortality [32].”
BackgroundLittle, J. P., Jung, M. E., Wright, A. E., Wright, W., & Manders, R. J. F. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0512 · Cited by 187
Costantino, S., Paneni, F., Battista, R., Castello, L., Capretti, G., Chiandotto, S., Tanese, L., Russo, G., Pitocco, D., Lanza, G. A., et al. (2017) · Diabetes · doi:10.2337/db17-0294 · Cited by 186
“Noteworthy, postprandial hyperglycemia is an independent risk factor for micro and macrovascular complications in T2D patients [40-42].”
BackgroundGuideline for management of postmeal glucose in diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.002 · Cited by 183
Wright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
Graduate Theses and Dissertations
Davis, M., Davis, K. J., & Dunagan, M. M. (2012) · Scientific Papers and Presentations · doi:10.1016/b978-0-12-384727-0.00006-9 · Cited by 164
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.016 · Cited by 148
Dempsey, P. C., Blankenship, J. M., Larsen, R. N., Sacre, J. W., Sethi, P., Straznicky, N. E., Cohen, N. D., Cerin, E., Lambert, G. W., Owen, N. G., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4169-z · Cited by 144
“Postprandial hyperglycaemia is linked to an increased risk of micro- and macro-vascular complications, particularly in individuals with type 2 diabetes [1, 2].”
BackgroundYou, Y.-W., Li, W., Liu, J., Li, X.-T., Fu, Y., & Ma, X.-D. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.697633 · Cited by 109
Bergouignan, A., Latouche, C., Heywood, S., Grace, M. S., Reddy-Luthmoodoo, M., Natoli, A. K., Owen, N., Dunstan, D. W., & Kingwell, B. A. (2016) · Scientific Reports · doi:10.1038/srep32044 · Cited by 121
Satoh, T. K., Igarashi, M., Yamada, S., Takahashi, N., & Watanabe, K. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.12.009 · Cited by 123
Imran, S. A., Agarwal, G., Bajaj, H. S., & Ross, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.030 · Cited by 113
Glycemic Variability: Both Sides of the Story
Ceriello, A., & Kilpatrick, E. S. (2013) · Diabetes Care · doi:10.2337/dcs13-2030 · Cited by 111
“Interestingly, the same author more recently reported that HbA1c instability, rather than that of glucose, is a predictor of microvascular complications in the same patients (7).”
BackgroundInfluentialVioli, F., Loffredo, L., Pignatelli, P., Angelico, F., Bartimoccia, S., Nocella, C., Cangemi, R., Petruccioli, A., Monticolo, R., Pastori, D., et al. (2015) · Nutrition & Diabetes · doi:10.1038/nutd.2015.23 · Cited by 111
Nishimura, R., Tanaka, Y., Koiwai, K., Inoue, K., Hach, T., Salsali, A., Lund, S. S., & Broedl, U. C. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0169-9 · Cited by 106
Xie, Y., Gou, L., Peng, M., Zheng, J., & Chen, L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.032 · Cited by 131
Ohara, M., Fukui, T., Ouchi, M., Watanabe, K., Suzuki, T., Yamamoto, S., Yamamoto, T., Hayashi, T., Oba, K., & Hirano, T. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.025 · Cited by 117
Borror, A., Zieff, G., Battaglini, C., & Stoner, L. (2018) · Sports Medicine · doi:10.1007/s40279-018-0864-x · Cited by 106
Evans, R. A., Frese, M., Romero, J., Cunningham, J. H., & Mills, K. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.145151 · Cited by 112
Modification of Insulin Sensitivity and Glycemic Control by Activity and Exercise
ROBERTS, C. K., LITTLE, J. P., & THYFAULT, J. P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318295cdbb · Cited by 95
“The mechanism behind these cross-sectional findings is that greater postprandial excursions or fluctuation are most tightly linked to CVD through the induction of oxidative stress and micro- and macrovascular damage (17).”
BackgroundInfluentialCavalot, F. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12140 · Cited by 95
“The San Luigi Gonzaga Diabetes Study is a prospective study started in 1995 aiming at evaluating the predictors of CV events and mortality in 529 Italian type 2 diabetic patients.”
BackgroundMethodInfluentialSelf-citationUtility of different glycemic control metrics for optimizing management of diabetes
Kohnert, K.-D. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.17 · Cited by 94
Mason, S. A., Rasmussen, B., van Loon, L. J. C., Salmon, J., & Wadley, G. D. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13571 · Cited by 93
Schell, J., Betts, N. M., Lyons, T. J., & Basu, A. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000497226 · Cited by 94
Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700225 · Cited by 88
Vascular AGE-ing by methylglyoxal: the past, the present and the future
Schalkwijk, C. G. (2015) · Diabetologia · doi:10.1007/s00125-015-3597-5 · Cited by 90
“Epidemiological studies support this concept, showing that glucose levels after an OGTT are an independent risk factor for cardiovascular disease (CVD), while fasting glucose levels are not, or are less so [5].”
BackgroundMacLeod, S. F., Terada, T., Chahal, B. S., & Boulé, N. G. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2461 · Cited by 87
“Postprandial glycemia is an independent predictor of future diabetic complications [7], including cardiovascular disease [8–10].”
BackgroundMikus, C. R., Oberlin, D. J., Libla, J., Boyle, L. J., & Thyfault, J. P. (2012) · Diabetologia · doi:10.1007/s00125-012-2490-8 · Cited by 85
Yamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13260 · Cited by 81
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
Selvin, E., Rawlings, A. M., Lutsey, P. L., Maruthur, N. M., Pankow, J. S., Steffes, M. W., & Coresh, J. (2015) · Diabetes · doi:10.2337/db15-0607 · Cited by 84
Madsbad, S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.019 · Cited by 84
“A direct association between PPG levels and cardiovascular events/all-cause mortality was also observed in the 14-year study follow-up [34].”
BackgroundOne Bout of Exercise Alters Free-Living Postprandial Glycemia in Type 2 Diabetes
OBERLIN, D. J., MIKUS, C. R., KEARNEY, M. L., HINTON, P. S., MANRIQUE, C., LEIDY, H. J., KANALEY, J. A., RECTOR, R. S., & THYFAULT, J. P. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182a54d85 · Cited by 76
“Key Words: POSTPRANDIAL GLUCOSE, GLYCEMIC CONTROL, EXERCISE, TYPE 2 DIABETES, CONTINUOUS GLUCOSE MONITORING H yperglycemia is linked to increased risk for cardiovascular disease (CVD) as well as all-cause mortality; thus, improved glycemic control is a critical target for diabetes management (6,33).”
BackgroundMethodInfluentialRole of Intestinal Bitter Sensing in Enteroendocrine Hormone Secretion and Metabolic Control
Xie, C., Wang, X., Young, R. L., Horowitz, M., Rayner, C. K., & Wu, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00576 · Cited by 77
Atherogenicity of postprandial hyperglycemia and lipotoxicity
Ceriello, A., & Genovese, S. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9341-8 · Cited by 84
Yu Pan, C., Han, P., Liu, X., Yan, S., Feng, P., Zhou, Z., Lv, X., Tian, H., Jin Kui, Y., Su, B., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2541 · Cited by 71
“PPG has also been shown to be superior to FPG at predicting cardiovascular disease and all-cause mortality [31].”
BackgroundKesavadev, J., Shankar, A., Pillai, P. B. S., Krishnan, G., & Jothydev, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0088 · Cited by 68
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
Saisho, Y. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030923 · Cited by 82
“Thus, reducing postprandial glycemic excursion and glycemic variability in patients with T2DM may improve CVD outcomes, although the role of glycemic variability in CVD outcome remains controversial [67–70].”
BackgroundSilva, F. M., Kramer, C. K., Crispim, D., & Azevedo, M. J. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195339 · Cited by 67
HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis
Cheng, D., Fei, Y., Liu, Y., Li, J., Qin, X. Y., Wang, X., & Wang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115509 · Cited by 75
The role of oxidative stress in postprandial endothelial dysfunction
Lacroix, S., Rosiers, C. D., Tardif, J.-C., & Nigam, A. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000182 · Cited by 64
“For instance, Kawano et al.(54) observed significant postprandial elevations in TBARS and attenuated flow-mediated dilatation of the brachial artery following an OGTT in subjects with IGT and T2DM while healthy controls were not significantly affected by such challenge.”
BackgroundInfluentialIqbal, N., Parker, A., Frederich, R., Donovan, M., & Hirshberg, B. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-33 · Cited by 61
“Although epidemiologic studies suggest that hyperglycemia is associated with adverse CV events [3-5], the effects of intensive glycemic control on CV outcomes in interventional studies are not clear [6-8].”
Tay, J., Thompson, C. H., & Brinkworth, G. D. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121214-104422 · Cited by 61
“Additionally, a substantial body of epidemiological (12, 14, 40, 59, 66, 71, 85, 101, 137, 149, 181, 211, 221, 224) and pathophysiological (53, 54, 166) studies provide further support that elevated PPG is an independent predictor and risk factor for CVD and all-cause mortality, increasing risk by 1.”
Backgroundde Carvalho, C. M., de Paula, T. P., Viana, L. V., Machado, V. M., de Almeida, J. C., & de Azevedo, M. J. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157263 · Cited by 73
Walsh, J. J., Neudorf, H., & Little, J. P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa925 · Cited by 58
Kieu, A., King, J., Govender, R. D., & Östlundh, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070855 · Cited by 73
Knudsen, S. H., Karstoft, K., Pedersen, B. K., van Hall, G., & Solomon, T. P. J. (2014) · Physiological Reports · doi:10.14814/phy2.12114 · Cited by 64
“Glycemic control is key in the management of type 2 diabetes (T2D), with postprandial glucose proposed as a better predictor of diabetes-related complications than fasting blood glucose or HbA1c (Cavalot et al. 2011).”
BackgroundKrishnakumar, A., Verma, R., Chawla, R., Sosale, A., Saboo, B., Joshi, S., Shaikh, M., Shah, A., Kolwankar, S., & Mattoo, V. (2021) · Journal of Medical Internet Research · doi:10.2196/17908 · Cited by 72
Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
Hershon, K. S., Hirsch, B. R., & Odugbesan, O. (2019) · Clinical Diabetes · doi:10.2337/cd18-0040 · Cited by 67
“In a 14-year follow-up of patients with type 2 diabetes managed in routine clinical practice, PPG and A1C, but not FPG, were found to have similar predictive power for CV events and all-cause mortality (20), whereas a review of a large number of epidemiological studies concluded that PPG is, in fact, a more powerful r…”
BackgroundShuaib, M., Ahmed, S., Ali, K., Ilyas, M., Hussain, F., Urooj, Z., Shah, S. S., Kumar, T., Shah, M., Khan, I., et al. (2018) · Acta Ecologica Sinica · doi:10.1016/j.chnaes.2018.04.006 · Cited by 55
Nesti, L., Mengozzi, A., & Tricò, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00144 · Cited by 53
Quan, M., Xun, P., Hua, W., Wang, J., Cheng, W., Cao, M., Zhou, T., Huang, T., Gao, Z., & Chen, P. (2020) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.12.006 · Cited by 61
Early therapy for type 2 diabetes in China
Yang, W., & Weng, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70136-6 · Cited by 57
Ahmad, A., Lim, L., Morieri, M. L., Tam, C. H. T., Cheng, F., Chikowore, T., Dudenhöffer‐Pfeifer, M., Fitipaldi, H., Huang, C., Kanbour, S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-023-00429-z · Cited by 82
Manousaki, D., Kent, J. W., Haack, K., Zhou, S., Xie, P., Greenwood, C. M., Brassard, P., Newman, D. E., Cole, S., Umans, J. G., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0769 · Cited by 49
Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology
Wu, Y., Ehlert, B., Metwally, A. A., Perelman, D., Park, H., Brooks, A. W., Abbasi, F., Michael, B., Celli, A., Bejikian, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03719-2 · Cited by 48
Cardiovascular disease prevention strategies for type 2 diabetes mellitus
Katsiki, N., Purrello, F., Tsioufis, C., & Mikhailidis, D. P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1351946 · Cited by 42
“More controversial is the effect of reducing postprandial glucose [239,240].”
BackgroundMartini, S., Solieri, L., Cattivelli, A., Pizzamiglio, V., & Tagliazucchi, D. (2021) · Biology · doi:10.3390/biology10060563 · Cited by 50
“perglycemia is deemed the principal pathogenic factor in T2D since high blood glucose levels are implicated in major health complications including cardiovascular diseases, neuropathy, nephropathy, and retinopathy [2,3].”
BackgroundHo, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40
Zhang, W., Kim, D., Philip, E., Miyan, Z., Barykina, I. N., Schmidt, B., & Stein, H. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0063-3 · Cited by 43
Hou, B., Zhao, Y., Ma, P., Xu, C., He, P., Yang, X., Zhang, L., Qiang, G., & Du, G. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)60022-x · Cited by 42
Bigaran, A., Zopf, E. M., Gardner, J. R., Gerche, A. L., Murphy, D. G., Howden, E. J., Baker, M. K., & Cormie, P. (2020) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-020-00273-5 · Cited by 42
High-Intensity Interval Training for Improving Postprandial Hyperglycemia
Little, J. P., & Francois, M. E. (2014) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2014.963474 · Cited by 37
“In particular, evidence has suggested that elevated postprandial hyperglycemia is an independent risk factor for cardiovascular disease and mortality in patients with T2D (Cavalot et al., 2006, 2011).”
BackgroundWang, X., Xie, C., Marathe, C. S., Malbert, C.-H., Horowitz, M., Jones, K. L., Rayner, C. K., Sun, Z., & Wu, T. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107951 · Cited by 37
Kang, X., Wang, C., Lifang, L., Chen, D., Yang, Y., Liu, G., Wen, H., Chen, L., He, L., Li, X., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0305 · Cited by 36
Picconi, F., Flaviani, A. D., Malandrucco, I., Giordani, I., & Frontoni, S. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.03.006 · Cited by 42
Takao, T., Suka, M., Yanagisawa, H., & Iwamoto, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12610 · Cited by 35
Russo, I., Viretto, M., Barale, C., Mattiello, L., Doronzo, G., Pagliarino, A., Cavalot, F. L., Trovati, M., & Anfossi, G. (2012) · Diabetes · doi:10.2337/db12-0040 · Cited by 37
Self-citationThe design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
Christensen, M., Miossec, P., Larsen, B. D., Werner, U., & Knop, F. K. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.942638 · Cited by 34
“However, there is evidence to suggest that postprandial hyperglycemia is a more accurate predictor of cardiovascular risk [12,13].”
BackgroundBauhinia forficata in the treatment of diabetes mellitus: a patent review.
de Souza, B. V. C., Moreira-Araújo, R. S. D. R., Silva, O. A., Faustino, L. C., Gonçalves, M. F. B., dos Santos, M. L., Souza, G. R., Rocha, L. D. M., Cardoso, M. L. S., & Nunes, L. C. C. (2018) · PubMed · doi:10.1080/13543776.2018.1409208 · Cited by 42
Santos, H. O., Genário, R., Macedo, R. C. O., Pareek, M., & Tinsley, G. M. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1819768 · Cited by 38
“Given that postprandial hyperglycemia is a risk factor for development of cardiovascular diseases (Cavalot et al. 2011; Levitan et al. 2004; O’Keefe and Bell 2007), the aforementioned pathways offer insights into the importance of the timing of food intake, which potentially speaks for personalized…”
BackgroundChen, M., Hu, C., & Jia, W. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.152 · Cited by 38
Khalafi, M., Ravasi, A. A., Malandish, A., & Rosenkranz, S. K. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109815 · Cited by 36
Nygaard, H., Rønnestad, B. R., Hammarström, D., Holmboe‐Ottesen, G., & Høstmark, A. T. (2017) · Europe PMC (PubMed Central) · Cited by 42
Li, J., Chattopadhyay, K., Xu, M., Chen, Y., Hu, F., Chu, J., & Li, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235161 · Cited by 36
Golay, A., Brock, E., Gabriel, R., Konrad, T., Lalic, N. M., Laville, M., Mingrone, G., Petrie, J. R., Phan, T., Pietiläinen, K. H., et al. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12114 · Cited by 34
Li, Z., Hu, Y., Yan, R., Li, H., Zhang, D., Li, F., Su, X., & Ma, J. (2018) · Medical Science Monitor · doi:10.12659/msm.910827 · Cited by 30
“Postprandial hyperglycemia is associated with an increased risk of diabetes complications [1–4], particularly in patients with type 2 diabetes [5,6].”
BackgroundHaldar, S., Egli, L., Castro, C. A. D., Tay, S. L., Koh, M. X. N., Darimont, C., Macé, K., & Henry, C. J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001099 · Cited by 36
Chen, C.-Y., Rasmussen, H., Kamil, A., Du, P., & Blumberg, J. B. (2017) · Nutrients · doi:10.3390/nu9020130 · Cited by 32
Zhang, X., Zheng, C., Ho, R. S. T., Miyashita, M., & Wong, S. H. (2022) · Sports Medicine - Open · doi:10.1186/s40798-021-00401-y · Cited by 36
Tuell, D. S., LOS, E. A., Ford, G. A., & Stone, W. L. (2023) · Antioxidants · doi:10.3390/antiox12061139 · Cited by 36
“PPG, 2 h after lunch, is a better predictor of cardiovascular events and all-cause mortality in T2D than fasting blood glucose levels [25,26].”
BackgroundRynarzewski, J., Dicks, L., Zimmermann, B. F., Stoffel‐Wagner, B., Ludwig, N., Helfrich, H., & Ellinger, S. (2019) · Nutrients · doi:10.3390/nu11020417 · Cited by 31
“In patients with T2D, postprandial hyperglycemia has shown to raise the incidence of cardiovascular disease (CVD) and all-cause mortality [2,3].”
BackgroundGan, T., Liao, B., & Xu, G. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.07.004 · Cited by 30
Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspects
Pang, J., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328354c790 · Cited by 35
Liu, Y., Xiao, X., Sun, C., Tian, S., Sun, Z., Gao, Y., Li, Y., Cheng, J., Lv, Y., Li, M., et al. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12498 · Cited by 28
Su, J., Yang, X., Zhang, X., Cai, H.-L., Huang, H., Zhao, L., Xu, F., Chen, T., Cheng, X., Wang, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183055 · Cited by 36
Mechanisms Underlying the Effect of Tea Extracts on In Vitro Digestion of Wheat Starch
Li, L., Xu, H., Zhou, J., Yu, J., Copeland, L., & Wang, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02526 · Cited by 30
Kameyama, N., Maruyama, C., Matsui, S., Araki, R., Yamada, Y., & Maruyama, T. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513004194 · Cited by 28
“In addition, reduction of postprandial hyperglycaemia is also desirable as it is an independent risk factor for macrovascular disease in people with diabetes((1,4)).”
BackgroundPostprandial Glucose: Marker or Risk Factor?
Avogaro, A. (2011) · Diabetes Care · doi:10.2337/dc11-1442 · Cited by 29
“(10) add further evidence of the harmful relationship between postmeal glucose levels and CVD events.”
BackgroundClavel, P., Tiollier, E., Leduc, C., Fabre, M., Lacome, M., & Buchheit, M. (2022) · International Journal of Sports Physiology and Performance · doi:10.1123/ijspp.2021-0222 · Cited by 21
Controversies on how diabetes is diagnosed
Malkani, S., & DeSilva, T. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835168c0 · Cited by 35
Metadata
- Authors
- Cavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., & Trovati, M.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga Faculty of Medicine of Turin University, San Luigi Gonzaga Hospital, Turin, Italy
- Corresponding author
- Trovati, Mariella
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2237-2243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177732
- OpenAlex
- W2079118015
- Cited by
- 322
- References
- 25
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 24 · 2021: 21 · 2020: 25 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 32 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 17
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, postprandial blood glucose, cardiovascular events, all-cause mortality, HbA1c, glycemic control, cardiovascular risk factors, long-term prognosis
- MeSH terms
- Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Male, Middle Aged, Proportional Hazards Models, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.